Cobimetinib- and vemurafenib-induced granulomatous dermatitis and erythema induratum: A case report

Metastatic melanoma is an aggressive malignancy. Survival can be increased with the combination of BRAF and MEK inhibition. BRAF inhibitor-induced cutaneous toxicities can be attenuated with MEK inhibition. Here, we describe the first reported case of a patient with metastatic melanoma who developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Iafolla, Marco AJ, Ramsay, Jennifer, Wismer, Judy, McWhirter, Elaine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
JCMS case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537058/
https://www.ncbi.nlm.nih.gov/pubmed/31205706
http://dx.doi.org/10.1177/2050313X19847358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537058/
https://www.ncbi.nlm.nih.gov/pubmed/31205706
http://dx.doi.org/10.1177/2050313X19847358

Ejemplares similares